Pallavi Agarwal
Noida, UP, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Epigenetic targeting of MECOM/KRAS axis by JIB-04 impairs tumorigenesis and cisplatin resistance in MECOM-amplified ovarian cancer.
Journal: Cell death discovery
Published: March 26, 2025
Counteracting methicillin resistant Staphylococcus aureus through novel Citral-Azithromycin combination.
Journal: Scientific reports
Published: February 28, 2025
Maternal Embryonic Leucine Zipper Kinase (MELK) as a Promising Therapeutic Target in Triple Negative Breast Cancer.
Journal: Anti-cancer agents in medicinal chemistry
Published: February 01, 2025
Deciphering Pharmacological Targets of Plumbagin in Cisplatin-resistant Ovarian Cancer Model using in vitro and in silico Approaches.
Journal: Current pharmaceutical design
Published: January 14, 2025
Efficacy and Safety of Curcumin as an Adjuvant to Standard Chemotherapy in Advanced and Metastatic Breast Cancer Patients: A Randomized Controlled Study.
Journal: Phytotherapy research : PTR
Published: June 02, 2024
Exploring the Synergistic Effect of Thymol with Oxacillin against Methicillin Resistant Staphylococcus aureus.
Journal: Indian journal of microbiology
Published: January 10, 2024
Editorial: Genetic regulation of mitosis and ploidy in cancer.
Journal: Frontiers in genetics
Published: July 21, 2023
Structure-based virtual screening for identification of potential CDC20 inhibitors and their therapeutic evaluation in breast cancer.
Journal: 3 Biotech
Published: October 14, 2022
Structure-based virtual screening of chemical libraries as potential MELK inhibitors and their therapeutic evaluation against breast cancer.
Journal: Chemico-biological interactions
Published: August 23, 2022
Synergistic action of Trichoderma koningiopsis and T. asperellum mitigates salt stress in paddy.
Journal: Physiology and molecular biology of plants : an international journal of functional plant biology
Published: August 15, 2021
Integrative genome wide analysis of protein tyrosine phosphatases identifies CDC25C as prognostic and predictive marker for chemoresistance in breast cancer.
Journal: Cancer biomarkers : section A of Disease markers
Published: July 19, 2021
Repurposing Drugs as Novel Triple-negative Breast Cancer Therapeutics.
Journal: Anti-cancer agents in medicinal chemistry
Published: January 10, 2021
Last Updated: 09/26/2026